2023
DOI: 10.1016/j.transproceed.2023.05.007
|View full text |Cite
|
Sign up to set email alerts
|

Understanding the Elevated Lethality of COVID-19 in Liver Transplant Recipients: Does Immunosuppression Management Matter? Results from a Brazilian Multicentric Historical Cohort

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 16 publications
0
1
0
Order By: Relevance
“…In a study exploring the effects of reducing/stopping immunosuppressant drugs in post-transplantation patients, discontinuation of tacrolimus was associated with an increase in the number of deaths; dose reduction of the agents reviewed did not affect outcomes. 59 …”
Section: Effects Of the Pandemic On Patients With Liver Diseasementioning
confidence: 99%
“…In a study exploring the effects of reducing/stopping immunosuppressant drugs in post-transplantation patients, discontinuation of tacrolimus was associated with an increase in the number of deaths; dose reduction of the agents reviewed did not affect outcomes. 59 …”
Section: Effects Of the Pandemic On Patients With Liver Diseasementioning
confidence: 99%